Related Experiment Video
Updated: Sep 25, 2025

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
Published on: December 22, 2017
Pathophysiology of deep vein thrombosis
Simón Navarrete1, Carla Solar1, Roberto Tapia2
1Thrombosis Research Center, Medical Technology School, Department of Clinical Biochemistry and Immunohaematology, Faculty of Health Sciences, Universidad de Talca, Av. Lircay s/n, 3460000, Talca, Chile.
Deep venous thrombosis (DVT) arises from acquired and hereditary factors. Recent research clarifies how altered blood flow, inflammation, and hemostasis interact to form blood clots.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pathophysiology
Background:
- Deep venous thrombosis (DVT) is a significant cause of illness and death.
- It results from acquired factors (e.g., hip fracture, immobility) and hereditary thrombophilias.
- The precise mechanisms of DVT are complex and involve multiple biological systems.
Purpose of the Study:
- To describe the key pathophysiological mechanisms of deep venous thrombosis.
- To highlight recent advances in understanding DVT development.
Main Methods:
- Review of current scientific literature on DVT pathophysiology.
- Synthesis of findings on venous flow, endothelial function, and cellular interactions.
Main Results:
- Altered venous blood flow causes endothelial activation.
- Platelets and leukocytes adhere, promoting coagulation via tissue factor and neutrophil extracellular traps.
- This process traps red blood cells, leading to thrombus formation and growth.
Conclusions:
- The pathophysiology of DVT involves a complex interplay of hemodynamic, inflammatory, and hemostatic factors.
- Understanding these mechanisms is crucial for developing effective prevention and treatment strategies.
More Related Videos
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Varicose Veins I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management

